Sign in
4

Changes in Ownership

Pacira BioSciences, Inc. Filed Acc 0001396814-25-000030

Chief Commercial Officer acquired 54,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Teehan Brendan Chief Commercial Officer 2025-02-01 Grant or award +54,000 54,000 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Teehan Brendan Chief Commercial Officer 2025-02-04 Grant or award · Stock Option (Right to Buy) +99,500 $26.59 $2,645,705 99,500 D: show line 2 in the form
Loading xslF345X05/wk-form4_1738711527.xml…